Pre-solicitationPosted Sep 10, 2026·Responses due Sep 20, 2026

Red Hat OpenShift Kubernetes Engine (OKE) and Red Hat Enterprise Linux (RHEL) Subscription Licensing and Deployment Support

National Institutes of Health · NATIONAL INSTITUTES OF HEALTH OLAO

Stage
Early notice (sources sought, presolicitation or special notice)
NAICS
513210
Value
Not stated
Solicitation
26-009442
Set-aside
None stated
PSC
7A21
Place
Bethesda, MD, USA
Contact
Shasheshe Goolsby (shasheshe.goolsby@nih.gov)
Loading your pipeline and notes…
CSV Email

Capture briefs (a one-page, shareable copy of this page) are part of Pro. The CSV here holds the notice, its timeline and past awards.

Where this opportunity stands

Every notice posted under solicitation 26-009442 in this department, oldest first.

Early notice
  • Sep 10, 2026 · this notice
    Pre-solicitation
Solicitation
None posted
Award
Not yet. Typical award: Oct 20, 2026 to Jul 12, 2027, middle of the range Nov 13, 2026.
Measured from 68 past early notices at National Institutes of Health that later posted an award (middle half of cases, counted from Sep 10, 2026).

Next steps for this stage

Standard steps for the notice type; not advice about this buyer.

  • Answer the notice: this is when the requirement can still be shaped.
  • Contact the contracting officer named on the notice.
  • Check who won similar work; they are the likely bidders.

What the notice says

The National Institutes of Health (NIH), Clinical Center (CC), Office of Purchasing and Contracts, intends to award a sole-source firm-fixed-price purchase order to Trilogy Innovations, Inc. for Red Hat OpenShift Kubernetes Engine (OKE) and Red Hat Enterprise Linux (RHEL) software subscriptions and associated deployment support. The requirement includes 40 Core Band subscriptions of Red Hat OpenShift Kubernetes Engine, Premium, Confirmed Stateside Support (SKU MW01016) and six Physical or Virtual Nodes of Red Hat Enterprise Linux Server with Satellite, Premium (SKU RH00008). The subscriptions … (show all)

include Premium Confirmed Stateside Support and are transferable within NIH's internal infrastructure. In addition to the software subscriptions, Trilogy Innovations will provide up to 20 hours of expert-level engineering services to support the initial deployment and configuration of Red Hat OpenShift Kubernetes Engine within the NIH environment. Services include installation, initial configuration and system readiness, operationalization of the environment for NIH workloads, identification of technical gaps and requirements necessary to support PAS-X onboarding and production readiness, review of the NIH PAS-X OKE environment architecture, and knowledge transfer and configuration documentation, as required. This acquisition is required to support the NIH Clinical Center's transition from paper-based processes and the unsupported StemLab application to the PAS-X application. The current StemLab application has not been supported by its vendor since June 2022. The Clinical Center must comply with strict manufacturing, documentation, and reporting requirements, including requirements applicable to the manufacture and distribution of human cells, tissues, and cellular and tissue-based products. The Red Hat licenses and deployment support will provide the infrastructure necessary for implementation of PAS-X and support the transition from the existing paper-based environment to electronic recordkeeping. Without this acquisition, the program would continue to operate at risk and may be unable to satisfy applicable federal and state requirements. The Government intends to procure this requirement from Trilogy Innovations, Inc. on a sole-source basis. The program office contacted Red Hat regarding the requirement, and Red Hat directed the program office to Trilogy Innovations as the third-party reseller for this acquisition. Trilogy will provide the Red Hat software subscriptions as a pass-through from Carahsoft Technology Corporation/Red Hat, Inc. and will perform the required deployment support. This contract will be for one year. RESPONSE TO NOTICE This Notice of Intent is not a request for competitive quotations or proposals. However, all responsible sources that believe they can satisfy the Government's requirements may submit a capability statement demonstrating their ability to provide the required Red Hat software subscriptions and deployment support. Interested parties must demonstrate their capability to provide the specified Red Hat OpenShift Kubernetes Engine and Red Hat Enterprise Linux subscriptions, including Premium Confirmed Stateside Support, as well as the required expert-level deployment and configuration services necessary to support NIH's PAS-X environment. Responses should include the company's legal business name, Unique Entity ID (UEI), CAGE Code, business size under NAICS 513210, point of contact, telephone number, email address, and sufficient technical documentation demonstrating the firm's ability to satisfy the complete requirement. Information received will be considered solely for the purpose of determining whether conducting a competitive procurement is in the best interest of the Government. A determination by the Government not to compete this proposed acquisition based upon responses to this notice is solely within the discretion of the Government. Responses must be submitted electronically to shasheshe.goolsby@nih.gov by September 20,2026 at 2:00PMEST.

Who won similar work

3 award notices on SAM.gov in the last 24 months. Matched by: Same agency (National Institutes of Health), same product/service code (PSC) 7A21.

Single-winner award sizes (3): middle half $212K to $4.8M, median $400K; range $24K to $9.2M.

WinnerAwardsValueLast
GARTNER, INC. · $IT · $6.5B1$9.2MSep 23, 2025
NETCOMM INC1$400KApr 2, 2025
A-TUNE SOFTWARE INC.1$24KSep 17, 2025

Value counts single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling; that ceiling is not one company's win, so it is not added in. Revenue next to a ticker is the company's last annual revenue from its 10-K.

Investor context
  • $IT reported $6.5B revenue (12 months to Jun 30, 2026). The median single-winner award in these 3 past awards, $400K, is under 0.1% of that. SEC filing

One award's total value against one year of revenue; many awards are paid over several years.

Latest awards

Materiality: one award's value as a share of the winner's revenue over the latest 12 months in its SEC filings (or its last fiscal year, as noted when you point at it). Low under 1%, Medium 1 to 5%, High 5% or more. Many awards are paid over several years, so this overstates a single year's share.

Competitive landscape

For the 3 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.

  • 0 of these past winners lobbied Natl Institutes of Health (NIH) since 2024 (0 filings)
  • 0 of their lobbyists list a past Natl Institutes of Health (NIH) job
  • No corporate PAC money from them to the overseeing committees since 2024
  • 0 foreign-agent (FARA) registrations
See who and the source records with Pro

Policy around it

Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.

  • 0 bills named on the past winners' lobbying filings
  • 0 rules from the department in the last 12 months
  • 0 executive orders naming the agency in the last 12 months
See who and the source records with Pro

Market

For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards. A sale marked 10b5-1 was made under a trading plan set up in advance.

  • 1 of the past winners are listed companies
  • 0 insider buys and 5 insider sells at them in the last 90 days
See who and the source records with Pro

Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.

Companies are matched to tickers by exact name only. A company we could not match shows no market rows; that is a miss, not a finding.